热门资讯> 正文
Sunshine Bizerma宣布公开募股定价600万美元
2026-10-08 20:17
- Sunshine Biopharma (SBFM) on Thursday announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the company expected to be about $6 million.
- The offering consists of 10.9M common units, each consisting of one share of common stock or one pre-funded warrant and two Series D warrants to purchase one share of common stock per warrant at an initial exercise price of $0.66.
- The public offering price per common unit is $0.55.
- The pre-funded warrants will be immediately exercisable and may be exercised at any time until exercised in full.
- The transaction is expected to close on or about October 9.
- The company expects to use the net proceeds from the offering for general corporate purposes and working capital.
- Press release
More on Sunshine Biopharma
- Seeking Alpha’s Quant Rating on Sunshine Biopharma
- Historical earnings data for Sunshine Biopharma
- Financial information for Sunshine Biopharma
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。